Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity
剖析花生四烯酸代谢途径在 PM 诱导的心脏代谢毒性的消退与进展中的作用
基本信息
- 批准号:10716093
- 负责人:
- 金额:$ 36.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdministrative SupplementAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease riskAntioxidantsArachidonate 5-LipoxygenaseArachidonic AcidsAstrocytesAtherosclerosisBrainCardiovascular DiseasesCardiovascular systemChronicCritical PathwaysDataDementiaDevelopmentDiesel ExhaustEnvironmental Risk FactorExposure toFatty LiverHeartHigh Fat DietImpaired cognitionImpairmentIncidenceInflammationInflammatoryKnock-outLaboratoriesLeadLipid PeroxidationLipoproteinsLow-Density LipoproteinsLungMetabolic DiseasesMetabolic PathwayMicrogliaMolecularMusNerve DegenerationNeuronsOxidative StressParticulate MatterPathway interactionsPersonsPhenotypePlasmaPlayResearchResolutionRisk FactorsRoleStudy modelsSymptomsSyndromeSystemTestingTissuesToxic effectTransgenic Micebrain tissuecardiometabolismcerebrovasculareffective therapylipid metabolismliver developmentmouse modelneuroinflammationneuron apoptosisneurotoxicitypreventresponseultrafine particle
项目摘要
PROJECT SUMMARY/ABSTRACT (AD-focused Administrative Supplement)
The estimated number of people with dementia is predicted to triple by 2050 worldwide. Together with the lack
of effective treatments to stop, slow or prevent Alzheimer's disease (AD) and its related dementias, the best
strategy to limit the predicted incidence is to mitigate AD risk factors. Exposure to ambient particulate matter
(PM) is emerging as a modifiable environmental risk factor for AD. However, the mechanism by which PM
exposure contributes to the development of AD is not known. Our previous research has shown that exposures
to ultrafine particles (UFP) and diesel exhaust (DE) in mice lead to chronic inflammation, increased lipid
peroxidation in lung and systemic tissues, disturbances in lipid metabolism and plasma lipoproteins, and the
development of liver steatosis and atherosclerosis, all components of the commonly called cardiometabolic
syndrome. Recent studies suggest that cardiovascular and metabolic disorders may play a critical role in the
development of AD. In fact, AD and cardiometabolic syndrome share major risk factors, in addition to
cerebrovascular and cardiovascular changes occurring years before symptoms occur. Based on additional
research from our laboratories, both UFP and DE exposures in mice trigger astrocyte and microglia activation
which lead to neuroinflammation and/or cause neurotoxicity affecting neurons in the brain and accelerating
cognitive decline. We will augment the Parental R01 (ES033703, RESTORE RFA) by extending its focus on
hepatic steatosis and atherosclerosis with the analyses of brain tissue in the same hyperlipidemic mouse model
(low-density lipoprotein knockout, Ldlr KO), placed on a high fat diet (HFD). Importantly, Ldlr deficiency and HFD
administration have been associated with worsened AD-related phenotypes and cognitive dysfunction in a
transgenic mouse model of AD through impairment of antioxidant system defenses leading to oxidative stress
and neuronal apoptosis. Therefore, while this is not a typical mouse model for the study of AD, we do expect
significant neuroinflammatory and neurodegenerative effects. Our overall objective is to identify critical
pathways in the Lung-Heart-Brain Axis that could be involved in the development of chronic inflammation in the
brain. Our hypothesis for this AD-focused Research Supplement is that PM exposure promotes
proinflammatory and degenerative effects in the brain via activation of the 5-Lipoxygenase pathway,
overpowering the counteracting actions of homeostatic protective responses when that activation is persistent.
Our hypothesis will be tested via the following aims: Supplemental Specific Aim 1) Determine molecular
pathways involved in the development and progression of neuroinflammation and AD-relevant changes in the
brain after exposure to UFP; and Supplemental Specific Aim 2) Dissect molecular pathways involved in the
development and progression of neuroinflammation and AD-relevant changes in the brain after exposure to DE.
Results from this Supplement could provide convincing preliminary data for additional proposals to investigate
environmental factors that may induce AD and other potential drivers of cognitive decline.
项目摘要/摘要(以 AD 为重点的行政补充)
预计到 2050 年,全球痴呆症患者人数将增加两倍。与缺乏一起
阻止、减缓或预防阿尔茨海默病 (AD) 及其相关痴呆症的有效治疗方法,最好的方法
限制预测发病率的策略是减轻 AD 风险因素。暴露于环境颗粒物
(PM) 正在成为 AD 的一个可改变的环境风险因素。然而,PM 的机制
暴露是否会导致 AD 的发展尚不清楚。我们之前的研究表明,暴露
超细颗粒物 (UFP) 和柴油机尾气 (DE) 会导致小鼠慢性炎症、血脂增加
肺和全身组织的过氧化、脂质代谢和血浆脂蛋白的紊乱以及
肝脏脂肪变性和动脉粥样硬化的发展,通常称为心脏代谢的所有组成部分
综合症。最近的研究表明,心血管和代谢紊乱可能在
AD的发展。事实上,AD 和心脏代谢综合征有共同的主要危险因素,除了
脑血管和心血管变化发生在症状出现前数年。基于附加
我们实验室的研究表明,小鼠的 UFP 和 DE 暴露都会触发星形胶质细胞和小胶质细胞激活
导致神经炎症和/或引起神经毒性,影响大脑中的神经元并加速
认知能力下降。我们将通过扩展其重点来增强 Parental R01(ES033703、RESTORE RFA)
同一高脂小鼠模型中肝脂肪变性和动脉粥样硬化的脑组织分析
(低密度脂蛋白敲除,Ldlr KO),采用高脂肪饮食(HFD)。重要的是,Ldlr 缺乏和 HFD
给药与 AD 相关表型恶化和认知功能障碍有关
AD转基因小鼠模型通过抗氧化系统防御受损导致氧化应激
和神经元凋亡。因此,虽然这不是 AD 研究的典型小鼠模型,但我们确实期望
显着的神经炎症和神经退行性作用。我们的总体目标是确定关键
肺-心-脑轴中的通路可能参与慢性炎症的发展
脑。我们对这份以 AD 为重点的研究补充的假设是,PM 暴露会促进
通过激活 5-脂氧合酶途径对大脑产生促炎和退行性作用,
当这种激活持续存在时,会压倒稳态保护反应的抵消作用。
我们的假设将通过以下目标进行检验: 补充具体目标 1) 确定分子
参与神经炎症的发生和进展以及 AD 相关变化的途径
暴露于 UFP 后的大脑;和补充具体目标 2) 剖析参与的分子途径
暴露于 DE 后大脑中神经炎症和 AD 相关变化的发生和进展。
本补充文件的结果可以为其他调查提案提供令人信服的初步数据
可能诱发 AD 的环境因素和认知能力下降的其他潜在驱动因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jesus Antonio Araujo其他文献
Jesus Antonio Araujo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jesus Antonio Araujo', 18)}}的其他基金
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity
剖析花生四烯酸代谢途径在 PM 诱导的心脏代谢毒性的消退与进展中的作用
- 批准号:
10570917 - 财政年份:2022
- 资助金额:
$ 36.21万 - 项目类别:
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity
剖析花生四烯酸代谢途径在 PM 诱导的心脏代谢毒性的消退与进展中的作用
- 批准号:
10350448 - 财政年份:2022
- 资助金额:
$ 36.21万 - 项目类别:
Interplay Between Macrophages, Lipid Oxidation and the Nrf2/HO-1 Axis in the Cardiometabolic Toxicity Induced by Ultrafine Particles
超细颗粒诱导的心脏代谢毒性中巨噬细胞、脂质氧化和 Nrf2/HO-1 轴之间的相互作用
- 批准号:
10576371 - 财政年份:2021
- 资助金额:
$ 36.21万 - 项目类别:
Interplay Between Macrophages, Lipid Oxidation and the Nrf2/HO-1 Axis in the Cardiometabolic Toxicity Induced by Ultrafine Particles
超细颗粒诱导的心脏代谢毒性中巨噬细胞、脂质氧化和 Nrf2/HO-1 轴之间的相互作用
- 批准号:
10181434 - 财政年份:2021
- 资助金额:
$ 36.21万 - 项目类别:
Interplay Between Macrophages, Lipid Oxidation and the Nrf2/HO-1 Axis in the Cardiometabolic Toxicity Induced by Ultrafine Particles
超细颗粒诱导的心脏代谢毒性中巨噬细胞、脂质氧化和 Nrf2/HO-1 轴之间的相互作用
- 批准号:
10402876 - 财政年份:2021
- 资助金额:
$ 36.21万 - 项目类别:
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles
肠道菌群在环境超细颗粒诱导的血脂异常和动脉粥样硬化中的作用
- 批准号:
10010319 - 财政年份:2019
- 资助金额:
$ 36.21万 - 项目类别:
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles
肠道菌群在环境超细颗粒诱导的血脂异常和动脉粥样硬化中的作用
- 批准号:
10462104 - 财政年份:2018
- 资助金额:
$ 36.21万 - 项目类别:
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles
肠道菌群在环境超细颗粒诱导的血脂异常和动脉粥样硬化中的作用
- 批准号:
10261570 - 财政年份:2018
- 资助金额:
$ 36.21万 - 项目类别:
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles
肠道菌群在环境超细颗粒诱导的血脂异常和动脉粥样硬化中的作用
- 批准号:
10005422 - 财政年份:2018
- 资助金额:
$ 36.21万 - 项目类别:
Air Pollution and Cardiovascular Diseases: Identification of Novel Biomarkers
空气污染和心血管疾病:新型生物标志物的鉴定
- 批准号:
8893819 - 财政年份:2015
- 资助金额:
$ 36.21万 - 项目类别:
相似海外基金
South Carolina Clinical & Translational Research Institute (SCTR)
南卡罗来纳州临床
- 批准号:
10820346 - 财政年份:2023
- 资助金额:
$ 36.21万 - 项目类别:
Optimizing Environmental Enrichment to Model Preclinical Neurorehabilitation
优化环境富集以模拟临床前神经康复
- 批准号:
10789355 - 财政年份:2023
- 资助金额:
$ 36.21万 - 项目类别:
Exploring CRMP5 as a novel target for Alzheimers disease
探索 CRMP5 作为阿尔茨海默病的新靶点
- 批准号:
10712329 - 财政年份:2022
- 资助金额:
$ 36.21万 - 项目类别:
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) - Pain Supplement
狼疮组学皮肤肾脏调查小组 (LOCKIT) - 疼痛补充剂
- 批准号:
10861419 - 财政年份:2022
- 资助金额:
$ 36.21万 - 项目类别: